CACHET B/C

CACHET B/C

A trial comparing the safety and efficacy of bivalirudin/Angiomax plus abciximab with heparin plus abciximab in patients undergoing PCI.

Primary endpoints
In-hospital MACE.
 
Conclusion
Bivalirudin ± provisional abciximab had fewer major adverse outcomes than heparin/abciximab.